Life Extension Magazine March 2005
Nutritional Strategies for Conquering Colon Cancer
By Debra Fulghum Bruce, PhD
Fiber. Despite 30 years of study, data on the association between dietary fiber and colon cancer risk are still inconclusive. A much-publicized study by Harvard University scientists in 1999 found no correlation between dietary fiber intake and colorectal cancer risk.25 Other studies, however, suggest that dietary fiber may indeed reduce the risk of colon cancer.26 An American Cancer Society study examined the relationship between colon cancer and the consumption of whole grains, fruits, vegetables, and dietary fiber. They found that men with the highest vegetable intake experienced reduced risk, while men with the lowest intake of vegetables and dietary fiber were at greater risk.27 Since fiber-rich fruits and vegetables are known for their many other health-promoting benefits, it seems prudent to consume them in abundance while scientists continue to unravel dietary fiber’s association with colon cancer.
Selenium. An essential trace mineral, selenium is one of the most important cancer-preventive nutrients. Scientists have noted a statistically significant correlation between low soil concentrations of selenium and increased rates of colorectal cancer.28 Scientists believe that selenium-poor soils contribute to low dietary selenium intake by their influence on the nutritional quality of locally grown foods. In studies, selenium compounds have inhibited tumor formation in various animal models, and other research suggests that supplemental selenium may reduce cancer risk in humans.29 Selenium is incorporated in numerous proteins in the body, including glutathione peroxidase, a powerful antioxidant. These selenium-containing proteins appear to offer antioxidant protection from reactive oxygen species that can damage DNA and alter protein function.30
Patients prone to colon adenomas have demonstrated low selenium levels. Supplementation can normalize selenium levels and thus may reduce the incidence of colon cancer.30 Epidemiological studies suggest that selenium reduces the risk of certain cancers, including colon cancer.31
Omega-3 fatty acids. Fish oil contains the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Epidemiological studies and animal experiments suggest that both EPA and DHA exert protective effects against colon cancer.32 In patients with colon cancer, EPA and DHA decrease cell proliferation and favorably modulate the balance between colon cell proliferation and apoptosis.32 In a laboratory study of mice, University of Texas researchers found that omega-3 fatty acids block the action of a chemical called protein kinase C beta II, which is thought to promote colon cancer, suggesting a potential role for omega-3 fatty acids in preventing colon cancer.33
A considerable body of literature suggests that specific compounds in tea, red wine, and turmeric (curcumin) inhibit the COX enzymes, thus reducing prostaglandin-mediated effects on the colon. Because colon tumors have been shown to strongly express the COX-2 protein, and many cancer-preventive NSAIDs suppress the COX enzymes, it is tempting to speculate that these functional food compounds may help to prevent colon cancer by inhibiting one or both forms of the COX enzyme.
Green tea. Green tea is rich in polyphenolic compounds, with catechins as its major component. Studies have shown that catechins possess diverse pharmacological properties that include antioxidant, anti-inflammatory, anticarcinogenic, anti-arteriosclerotic, and antibacterial effects. In the gastrointestinal tract, green tea has been shown to activate intracellular antioxidants, inhibit pro-carcinogen formation, and suppress angiogenesis and cancer cell proliferation.34
The most prominent catechin in green tea is epigallocatechin-3 gallate (EGCG), which modulates numerous molecular targets in the presence of inflammation and cancer.35 In-vitro cell culture studies show that tea polyphenols potently induce apoptotic cell death and cell cycle arrest in tumor cells but not in their normal cell counterparts.36 Animal studies have revealed that green tea inhibits tumor incidence and multiplicity in the colon and other organ sites.36
A large, population-based, case-controlled study in China found that consuming green tea reduced the risk of cancers of the colon, rectum, and pancreas.37 Tea polyphenols have been found to influence the metabolism of arachidonic acid in human colon mucosa cells and colon tumors by inhibiting the lipoxygenase and cylooxygenase enzymes. This mechanism may be responsible for some of green tea’s protective effects against colon cancer.38
Resveratrol. A red wine poly-phenol, resveratrol is considered cancer chemopreventive because of its antioxidant and antimutagenic effects.12 Inflammatory bowel disease in humans is known to be a major risk factor for colon cancer. In an animal study, resveratrol reduced the tissue injury caused by experimentally induced colitis, and also alleviated oxidative damage.39 These promising results suggest a role for resveratrol in modulating colon cancer risk, particularly for those at heightened risk because of inflammatory bowel disease.
Curcumin. Extensive research during the past 50 years indicates that curcumin (diferuloylmethan), the yellow pigment in the curry spice turmeric, can prevent and treat cancer. The lower incidences of colon cancer in Asian nations have been attributed to their intake of curcumin, which has been widely used for centuries without toxic effects. This phytonutrient inhibits some COX-2 while also inhibiting the actions of lipooxygenase, another enzyme involved in inflammation. Curcumin also inhibits the promotion and progression stages of carcinogenesis in cell cultures and animal studies.13
Scientists have theorized that cancer incidence at different body sites may be related to oxidative damage, which may in turn be modified by plant phytochemicals. When scientists from India’s National Institute of Nutrition studied curcumin’s protective effect against DNA damage in human cells, they concluded that this non-nutritive dietary constituent possesses antimutagenic properties and appears to be a promising chemopreventive agent.40
In the past year, researchers at the MD Anderson Cancer Center in Houston, TX, have revealed how various synthetic NSAIDs such as aspirin and ibuprofen, as well as natural compounds such as curcumin and resveratrol, that inhibit tumor cell proliferation. Recently published in the journal Oncogene, the study concluded that resveratrol and curcumin were among the most potent anti-inflammatory and antiproliferative agents, while aspirin and ibuprofen were (surprisingly) among the least potent.41
The prevalence of colon cancer is frighteningly high, and the disease will kill some 57,000 Americans this year. You can begin a program of colon cancer prevention today by heeding the myriad studies that endorse the importance of a healthy diet and lifestyle, dietary supplementation, and preventive screening.42 The good news is that colon cancer’s lethality could be greatly reduced with widespread and regular screening by colonoscopy. A colonoscopy allows for the removal of precancerous polyps before they develop into cancerous lesions. If an early-stage cancerous lesion is detected, the chance of curing it is very good. If one waits for physical symptoms of colon cancer to manifest, however, the mortality risk is terribly high.
1. Pinsky PF, Kramer BS, Reding D, Buys S. Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol. 2003 May 1;157(9):792-9.
2. Eddy DM. Screening for colorectal cancer. Ann Intern Med. 1990 Sep 1;113(5):373-84.
3. Fung T, Hu FB, Fuchs C, et al. Major dietary patterns and the risk of colorectal cancer in women. Arch Intern Med. 2003 Feb 10;163(3):309-14.
4. Steinberg SM, Barkin JS, Kaplan RS, Stablein DM. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer. 1986 May 1;57(9):1866-70.
5. Chao A, Connell CJ, Cokkinides V, et al. Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults. Am J Public Health. 2004 Oct;94(10):1775- 81.
6. Waddell WR, Ganser GF, Cerise EJ, Loughry RW. Sulindac for polyposis of the colon. Am J Surg. 1989 Jan;157(1):175-9.
7. Wang D, Wang H, Shi Q, et al. Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell. 2004 Sep;6(3):285-95.
8. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232-5.
9. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995 Sep 7;333(10):609-14.
10. Boyer J, Liu RH. Apple phytochemicals and their health benefits. Nutr J. 2004 May 12;3(1):5.
11. Peters U, Sinha R, Chatterjee N, et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet. 2003 May 3;361(9368):1491-5.
12. Bhat KP, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann NY Acad Sci. 2002 May;957:210-29.
13. Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des. 2002;8(19):1695-706.
14. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003 Nov;133(11 Suppl 1):3731S-9S.
15. Duthie SJ, Narayanan S, Brand GM, Grant G. DNA stability and genomic methylation status in colonocytes isolated from methyl-donor-deficient rats. Eur J Nutr. 2000 Jun;39(3):106-11.
16. Available at: http://www.prohealthlibrary.com/library/print.cfm?ID=150&t=Health. Accessed December 7, 2004.
17. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann Intern Med. 1998 Oct 1;129(7):517-24.
18. Harnack L, Jacobs DR, Jr., Nicodemus K, et al. Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer. 2002;43(2):152-8.
19. Newmark HL, Heaney RP, Lachance PA. Should calcium and vitamin D be added to the current enrichment program for cereal- grain products? Am J Clin Nutr. 2004 Aug;80(2):264-70.
20. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 2000 Nov;95(11):3053-63.
21. Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL. Calcium intake and risk of colon cancer in women and men. J Natl Can cer Inst. 2002 Mar 20;94(6):437-46.
22. Wallace K, Baron JA, Cole BF, et al. Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst. 2004 Jun 16;96(12):921-5.
23. Holt PR. Dairy foods and prevention of colon cancer: human studies. J Am Coll Nutr. 1999 Oct;18(5 Suppl):379S-91S.
24. Grau MV, Baron JA, Sandler RS, et al. Vita- min D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003 Dec 3;95(23):1765-71.
25. Fuchs CS, Giovannucci EL, Colditz GA, et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med. 1999 Jan 21;340(3):169-76.
26. Lieberman DA, Prindiville S, Weiss DG, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003 Dec 10;290(22):2959-67.
27. McCullough ML, Robertson AS, Chao A, et al. A prospective study of whole grains, fruits, vegetables and colon cancer risk. Cancer Causes Control. 2003 Dec;14(10):959-70.
28. Ferguson LR, Philpott M, Karunasinghe N. Dietary cancer and prevention using antimutagens. Toxicology. 2004 May 20;198(1- 3):147-59.
29. Combs GF, Jr., Gray WP. Chemopreventive agents: selenium. Pharmacol Ther. 1998 Sep;79(3):179-92.
30. Al Taie OH, Seufert J, Karvar S, et al. Selenium supplementation enhances low selenium levels and stimulates glutathione peroxidase activity in peripheral blood and distal colon mucosa in past and present carriers of colon adenomas. Nutr Cancer. 2003;46(2):125-30.
31. Borek C. Dietary antioxidants and human cancer. Integr Cancer Ther. 2004 Dec;3(4):333-41.
32. Simopoulos AP. The traditional diet of Greece and cancer. Eur J Cancer Prev. 2004 Jun;13(3):219-30.
33. Murray NR, Weems C, Chen L, et al. Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon car- cinogenesis. J Cell Biol. 2002 Jun 10;157(6):915-20.
34. Koo MW, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol. 2004 Oct 1;500(1-3):177- 85.
35. Aneja R, Hake PW, Burroughs TJ, et al. Epi-gallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med. 2004 Jan;10(1-6):55-62.
36. Chen D, Daniel KG, Kuhn DJ, et al. Green tea and tea polyphenols in cancer prevention. Front Biosci. 2004 Sep 1;9:2618-31.
37. Ji BT, Chow WH, Hsing AW, et al. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer. 1997 Jan 27;70(3):255-8.
38. Hong J, Smith TJ, Ho CT, August DA, Yang CS. Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxy- genase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol. 2001 Nov 1;62(9):1175-83.
39. Martin AR, Villegas I, La Casa C, de la Lastra CA. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol. 2004 Apr 1;67(7):1399-410.
40. Polasa K, Naidu AN, Ravindranath I, Krish naswamy K. Inhibition of B(a)P induced strand breaks in presence of curcumin. Mutat Res. 2004 Feb 14;557(2):203-13.
41. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene. 2004 Oct 18.
42. Casimiro C. Etiopathogenic factors in colorectal cancer. Nutritional and life-style aspects. 2. Nutr Hosp. 2002 May;17(3):128- 38.
43. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol. 2000 Apr;95(4):868-77.
44. Wenzel U, Herzog A, Kuntz S, Daniel H. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004 Jul;4(7):2160-74.